{
  "meta": {
    "title": "12_Molecular_Basis_Of_Cancer_And_Tumor_Immunity",
    "url": "https://brainandscalpel.vercel.app/12-molecular-basis-of-cancer-and-tumor-immunity-734f9571.html",
    "scrapedAt": "2025-11-30T12:33:23.181Z"
  },
  "questions": [
    {
      "text": "Which of the following is overexpressed in patients diagnosed with glioma?",
      "choices": [
        {
          "id": 1,
          "text": "PDGF-β"
        },
        {
          "id": 2,
          "text": "ERB-1"
        },
        {
          "id": 3,
          "text": "RET"
        },
        {
          "id": 4,
          "text": "NGF"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Gliomas</strong> show overexpression of <strong>PDGF-&beta;</strong>&nbsp;and <strong>TGF-&alpha;.</strong></p>\n<p>Isocitrate dehydrogenase (IDH) <strong>wild-type</strong> glioblastomas are associated with epidermal growth factor receptor (<strong>EGFR</strong>)&nbsp;<strong>amplification</strong>&nbsp;and homozygous <strong>CDKN2A deletion.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4158",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is associated with loss of function mutation in RET proto-oncogene?",
      "choices": [
        {
          "id": 1,
          "text": "Medullary carcinoma of the thyroid"
        },
        {
          "id": 2,
          "text": "Pheochromocytoma"
        },
        {
          "id": 3,
          "text": "Hirschsprung disease"
        },
        {
          "id": 4,
          "text": "Pituitary adenoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Loss of function</strong> mutation in <strong>RET proto-oncogene</strong> is associated with <strong>Hirschsprung's disease.</strong></p>\n<p>Hirschsprung's disease is caused by <strong>mutations</strong> in other genes encoding proteins involved in <strong>enteric neurodevelopment</strong>. These include:</p>\n<ul>\n<li>RET ligand glial-derived neurotrophic factor</li>\n<li>Endothelin</li>\n<li>Endothelin receptor</li>\n</ul>\n<p>Note: <strong>Medullary thyroid carcinoma </strong>and<strong> multiple endocrine neoplasias,</strong> types <strong>2A</strong> and <strong>2B </strong>are usually due to <strong>gain of function</strong> mutations in RET proto-oncogene.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4163",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following tumors is associated with mutation of the ALK receptor?",
      "choices": [
        {
          "id": 1,
          "text": "Colon carcinoma"
        },
        {
          "id": 2,
          "text": "Pancreatic carcinoma"
        },
        {
          "id": 3,
          "text": "Glioma"
        },
        {
          "id": 4,
          "text": "Neuroblastoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Anaplastic lymphoma kinase (<strong>ALK</strong>) is a membrane-bound <strong>receptor tyrosine kinase</strong>. When aberrantly expressed, it is associated with&nbsp;<strong>neuroblastoma</strong> pathogenesis. It serves as a <strong>therapeutic target.</strong></p>\n<p><strong>Neuroblastoma</strong> is one of the <strong>most common solid cancers</strong> among <strong>children</strong>.</p><hr><h3>Related Pearl: Growth Factor Receptors and Associated Tumors</h3><p><strong>Growth factor receptors and Associated Tumors</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Category</p>\n</td>\n<td>\n<p><em>Proto-Oncogene</em></p>\n</td>\n<td>\n<p>Mode of activation</p>\n</td>\n<td>\n<p>Associated tumor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EGF-receptor family</p>\n</td>\n<td>\n<p><em>ERBB1 (EGFR)</em></p>\n<p><em>ERBB2 (HER)</em></p>\n</td>\n<td>\n<p>Mutation</p>\n<p>Amplification</p>\n</td>\n<td>\n<p>Adenocarcinoma of lung</p>\n<p>Breast carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FMS- like tyrosine kinase 3</p>\n</td>\n<td>\n<p><em>FLT3</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Receptor for neurotrophic factors</p>\n</td>\n<td>\n<p><em>RET</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Multiple endocrine neoplasia 2A and B, familial medullary thyroid carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PDGF receptor</p>\n</td>\n<td>\n<p><em>PDGFRB</em></p>\n</td>\n<td>\n<p>Overexpression, translocation</p>\n</td>\n<td>\n<p>Gliomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Receptor for KIT ligand</p>\n</td>\n<td>\n<p><em>KIT</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Gastrointestinal stromal tumors, seminomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ALK receptors</p>\n</td>\n<td>\n<p><em>ALK</em></p>\n</td>\n<td>\n<p>Translocation, fusion gene formation</p>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Adenocarcinoma of lung, certain lymphomas</p>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4165",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presents with a painless loss of vision. Fundus examination reveals the lesion shown in the image. Which of the following GTP-binding proteins show point mutations in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "NRAS"
        },
        {
          "id": 2,
          "text": "KRAS"
        },
        {
          "id": 3,
          "text": "GNAQ"
        },
        {
          "id": 4,
          "text": "GNAS"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario and fundus examination are suggestive of&nbsp;<strong>uveal melanoma&nbsp;</strong>which is associated with a point&nbsp;mutation of&nbsp;<strong>GNAQ</strong>&nbsp;protein&nbsp;or GNA11 genes.</p>\n<p>Uveal melanomas (UM) originate from melanocytes in the interior wall of the eye. This includes the iris, ciliary body, and the choroid with marked differences in light exposure (from dark anterior to illuminated posterior).</p>\n<p><strong>GNAS</strong> mutation causes <strong>pituitary adenoma</strong> and other <strong>endocrine tumors.</strong></p>\n<p>The<strong> 3 RAS genes</strong> in humans (<em><strong>H-RAS</strong></em>, <strong><em>K-RAS</em>,</strong> and <strong><em>N-RAS</em></strong>) are the most common oncogenes in human cancer. They code for a family of proteins called<strong> GTP-binding (G) proteins,</strong> which are involved in transmitting signals within cells (cellular signal transduction). When RAS is 'switched on' by incoming signals, it subsequently switches on other proteins, which ultimately results in cell growth, differentiation, and survival.</p>\n<p><strong>Mutations</strong> in <strong>RAS</strong> genes can lead to the production of <strong>permanently activated</strong> RAS proteins. As a result, this can cause unintended and <strong>overactive</strong> <strong>signaling</strong> inside the cell, even in the absence of incoming signals. Because these signals result in cell growth and division, overactive RAS signaling can ultimately lead to <strong>cancer</strong>.</p><hr><h3>Related Pearl: Cancers associated with important oncogenes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Oncogenes</strong></p>\n</td>\n<td><strong>Associated cancers</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>c-MYC</em></p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma</p>\n<p>Adenocarcinomas of the breast, lung, and colon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>N-MYC</em></p>\n</td>\n<td>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>L-MYC</em></p>\n</td>\n<td>\n<p>Small-cell carcinoma of the lung</p>\n</td>\n</tr>\n<tr>\n<td><em>K-RAS</em></td>\n<td>Colon, lung, and pancreatic tumors</td>\n</tr>\n<tr>\n<td><em>N-RAS</em></td>\n<td>\n<p>Melanoma</p>\n<p>AML</p>\n</td>\n</tr>\n<tr>\n<td><em>H-RAS</em></td>\n<td>Bladder and kidney tumors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f137121a79504df7a8c4b29e84c86a8e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4169",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following are coded by the MYC genes?",
      "choices": [
        {
          "id": 1,
          "text": "Cell cycle regulators"
        },
        {
          "id": 2,
          "text": "Nuclear regulatory proteins"
        },
        {
          "id": 3,
          "text": "Signal transduction proteins"
        },
        {
          "id": 4,
          "text": "Growth factor receptors"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>MYC oncogene </strong>codes for <strong>nuclear regulatory proteins</strong>. It is the most commonly involved<strong> transcription factor </strong>in&nbsp;tumors.</p>\n<p>The MYC proto-oncogene MYC activates the expression of many genes that are involved in cell growth. It&nbsp;<strong>upregulates</strong> the expression of <strong>telomerase</strong> and&nbsp;reprograms somatic cells into pluripotent stem cells.</p><hr><h3>Related Pearl: Cancers associated with important oncogenes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Oncogenes</strong></p>\n</td>\n<td><strong>Associated cancers</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>c-MYC</em></p>\n</td>\n<td>\n<p>Burkitt&rsquo;s lymphoma</p>\n<p>Adenocarcinomas of the breast, lung, and colon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>N-MYC</em></p>\n</td>\n<td>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>L-MYC</em></p>\n</td>\n<td>\n<p>Small-cell carcinoma of the lung</p>\n</td>\n</tr>\n<tr>\n<td><em>K-RAS</em></td>\n<td>Colon, lung, and pancreatic tumors</td>\n</tr>\n<tr>\n<td><em>N-RAS</em></td>\n<td>\n<p>Melanoma</p>\n<p>AML</p>\n</td>\n</tr>\n<tr>\n<td><em>H-RAS</em></td>\n<td>Bladder and kidney tumors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4173",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is associated with the translocation of cyclin D1?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Non-Hodgkin's lymphoma"
        },
        {
          "id": 3,
          "text": "Acute lymphoblastic leukemia"
        },
        {
          "id": 4,
          "text": "Mantle cell lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Translocation </strong>of<strong> cyclin D1</strong> is seen in <strong>mantle cell lymphoma.</strong></p>\n<p>Mantle cell lymphoma is an uncommon lymphoid neoplasm that is characterized by <span data-preserver-spaces=\"true\">overexpression of cyclin D1. It is a type of non Hodgkins lymphoma that involves</span> <strong><span data-preserver-spaces=\"true\">(11;14) translocation </span></strong>i.e. between<span data-preserver-spaces=\"true\"> <strong>IgH locus</strong> on </span><strong><span data-preserver-spaces=\"true\">chromosome 14</span></strong> and the<strong><span data-preserver-spaces=\"true\"> cyclin D1</span></strong><span data-preserver-spaces=\"true\"> </span>locus on <strong><span data-preserver-spaces=\"true\">chromosome 11.</span></strong></p><hr><h3>Related Pearl: Cell Cycle Regulators and Associated Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Cell cycle regulator</strong></p>\n</td>\n<td>\n<p><strong>Proto-oncogene</strong></p>\n</td>\n<td>\n<p><strong>Mode of activation in tumor</strong></p>\n</td>\n<td>\n<p><strong>Associated tumor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cyclins</p>\n</td>\n<td>\n<p>CCND1 (Cyclin D1)</p>\n</td>\n<td>\n<p>Translocation</p>\n<p>Amplification</p>\n</td>\n<td>\n<p>Mantle cell lymphoma, multiple myeloma</p>\n<p>Breast and esophageal cancers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cyclin-dependent kinase</p>\n</td>\n<td>\n<p>CDK4</p>\n</td>\n<td>\n<p>Amplification or point mutation</p>\n</td>\n<td>\n<p>Glioblastoma, melanoma, sarcoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4176",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is false about Knudson's two-hit hypothesis theory on retinoblastoma?",
      "choices": [
        {
          "id": 1,
          "text": "Familial type is inherited as an autosomal recessive trait"
        },
        {
          "id": 2,
          "text": "It involves both alleles of RB at chromosome locus 13q14"
        },
        {
          "id": 3,
          "text": "In sporadic cases, both normal RB alleles must undergo somatic mutation in the same retinoblast"
        },
        {
          "id": 4,
          "text": "In familial cases, children inherit one defective copy of the RB gene and the other copy is normal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Retinoblastoma</strong> is inherited as an <strong>autosomal dominant</strong> trait.</p>\n<p>Knudson's hypothesis, also known as the <strong>two-hit hypothesis</strong> or multiple-hit hypothesis states that <strong>cancer </strong>is the result of accumulated<strong> mutations </strong>in a cell's<strong> DNA. </strong>Two mutations (hits), involving both alleles of RB at <strong>chromosome locus 13q14</strong>, are required to produce retinoblastoma.</p>\n<p>In <strong>familial cases</strong>, children inherit one defective copy of the RB gene in the germline (the <strong>first hit</strong>), and the other copy is normal.&nbsp;Retinoblastoma develops when the normal RB allele is mutated in retinoblasts as a result of a spontaneous somatic mutation (the <strong>second hit</strong>).&nbsp;Most individuals inheriting a germline defect in one RB allele develop unilateral or bilateral retinoblastoma as it is an&nbsp;<strong>autosomal dominant</strong> disease.</p>\n<p><strong>Sporadic cases</strong> are comparitively rare. In sporadic cases, both normal RB alleles must undergo somatic mutation in the same retinoblast (<strong>two hits</strong>).</p>\n<p>The image given below shows the Knudson's two-hit hypothesis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8d3bea1f169a41bba92e0c8d3aeb9c75x1217x526.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4180",
      "difficulty": "medium"
    },
    {
      "text": "If the RB gene is hypophosphorylated, which of the following will happen?",
      "choices": [
        {
          "id": 1,
          "text": "Cell cycle will stop at G2"
        },
        {
          "id": 2,
          "text": "Cell cycle will stop at G1"
        },
        {
          "id": 3,
          "text": "There will be no effect on cell cycle as RB gene phosphorylation is not needed"
        },
        {
          "id": 4,
          "text": "The cell cycle progresses and cell divides"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>If the retinoblastoma (<strong>RB</strong>) gene is <strong>hypophosphorylated</strong>, it is <strong>active</strong> and the cell cycle will<strong> stop </strong>at<strong> G1</strong>.</p>\n<p>RB is a<strong> cell-cycle regulator</strong> because it binds to and inactivates a transcription factor (<strong>E2F</strong>). This is necessary for the transcription of certain genes necessary for the progression from the G1 to S phase.<strong>&nbsp;</strong>The<strong> phosphorylation </strong>of<strong> RB</strong>&nbsp;results in the&nbsp;release of E2F. This activates gene transcription and cell-cycle<strong> progression </strong>occurs.</p>\n<p>The image given below shows the cell cycle regulation by RB gene.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/167150cafdc746c092057263a6861018x1280x837.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9447",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about p53?",
      "choices": [
        {
          "id": 1,
          "text": "It regulates cellular senescence"
        },
        {
          "id": 2,
          "text": "P53 inactivation causes cell cycle arrest at G2-M"
        },
        {
          "id": 3,
          "text": "Cancers demonstrate biallelic loss of function mutations in TP53"
        },
        {
          "id": 4,
          "text": "p53  can be inactivated by E6 protein of HPV"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>P53</strong> is the<strong> tumor suppressor gene</strong> and <strong>activation</strong> (not inactivation) causes cell cycle arrest at the&nbsp;<strong>G1-S </strong>and<strong> G2-M</strong> phase of the&nbsp;cell cycle.<strong>&nbsp;</strong></p>\n<p>P53 regulates:</p>\n<ul>\n<li>Cell cycle progression</li>\n<li>DNA repair</li>\n<li><strong>Cellular senescence</strong></li>\n<li>Apoptosis</li>\n</ul>\n<p>It is activated by:</p>\n<ul>\n<li>Anoxia</li>\n<li>Inappropriate signaling by mutated oncoproteins</li>\n<li>DNA damage</li>\n</ul>\n<p>It is the<strong> most frequently </strong>mutated gene in<strong>&nbsp;cancers.</strong>&nbsp;It&nbsp;upregulates the expression of proteins such as the cyclin-dependent kinase inhibitor p21, thereby causing cell-cycle arrest at the <strong>G1-S.</strong>&nbsp;It also<strong>&nbsp;transactivates </strong>and<strong>&nbsp;transrepresses </strong>target gene to induce<strong> G2/M arrest.&nbsp;</strong>Mutation in the p53 gene causes <strong>resistance </strong>in tumors to <strong>radiation </strong>and<strong> chemotherapy</strong>.</p>\n<p>The <strong>E6</strong> protein of human papillomavirus (<strong>HPV</strong>) binds to and helps in the <strong>degradation</strong> of <strong>p53</strong> and stimulates the expression of telomerase reverse transcriptase (<strong>TERT</strong>), which is the catalytic subunit of telomerase, thereby helping in the&nbsp;<strong>longevity</strong>&nbsp;of the cells.&nbsp;E6 from high-risk HPV types has a&nbsp;<strong>higher affinity</strong>&nbsp;for p53 than E6 from low-risk types.&nbsp;</p>\n<p><strong>Li-Fraumeni syndrome</strong>&nbsp;is an <strong>autosomal dominant </strong>disorder due to a defect in the tumor suppressor gene <strong>P53</strong> located on <strong>chromosome 17.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4182",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is essential for the differentiation of stratified squamous epithelia?",
      "choices": [
        {
          "id": 1,
          "text": "p53"
        },
        {
          "id": 2,
          "text": "p63"
        },
        {
          "id": 3,
          "text": "p53 and p63"
        },
        {
          "id": 4,
          "text": "p63 and p73"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>p63</strong> is essential for the <strong>differentiation </strong>of <strong>stratified squamous epithelia</strong>.</p>\n<p>p53 is ubiquitously expressed, while p63 and p73 show more tissue specificity.</p>\n<p><strong>p73</strong> has strong <strong>pro-apoptotic</strong> effects after DNA damage induced by chemotherapeutic agents.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4183",
      "difficulty": "medium"
    },
    {
      "text": "A 22-year-old man was found to have multiple GI polyps. He was operated on for thyroid cancer  2 years back. His family history is significant for breast cancer in his mother and endometrial cancer in his aunt. Germline loss-of-function mutations of which gene is associated with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "CDKN2A"
        },
        {
          "id": 2,
          "text": "SMAD2"
        },
        {
          "id": 3,
          "text": "APC"
        },
        {
          "id": 4,
          "text": "PTEN"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 306\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The given scenario is suggestive of<strong> Cowden syndrome</strong>.&nbsp;This condition is caused due to germline loss of function mutation in <strong>PTEN</strong> (phosphatase and tensin homolog) gene.</p>\n<p>PTEN is a membrane-associated phosphatase encoded by a gene on chromosome <strong>10q23</strong> that is mutated.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Cowden syndrome is characterized by skin appendage tumors&nbsp;and an increased incidence of epithelial cancers, particularly of the <strong>breast, endometrium, </strong>and<strong> thyroid. </strong></p><hr><h3>Related Pearl: Inhibitors of Mitogenic Signaling Pathway</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Gene</strong></p>\n</td>\n<td>\n<p><strong>Protein</strong></p>\n</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Familial Syndromes</strong></p>\n</td>\n<td>\n<p><strong>Sporadic Cancers</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>APC</em></p>\n</td>\n<td>\n<p>Adenomatous polyposis coli protein</p>\n</td>\n<td>\n<p>Inhibitor of WNT signaling</p>\n</td>\n<td>\n<p>Familial colonic polyps and carcinomas</p>\n</td>\n<td>\n<p>Carcinomas of stomach, colon, pancreas, melanoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>NF1</em></p>\n</td>\n<td>\n<p>Neurofibromin-1</p>\n</td>\n<td>\n<p>Inhibitor of RAS/MAPK signaling</p>\n</td>\n<td>\n<p>Neurofibromatosis type 1</p>\n<p>(neurofibromas and malignant peripheral nerve sheath tumors)</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Neuroblastoma, juvenile myeloid leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>NF2</em></p>\n</td>\n<td>\n<p>Merlin</p>\n</td>\n<td>\n<p>Cytoskeletal stability, Hippo pathway signaling</p>\n</td>\n<td>\n<p>Neurofibromatosis type 2 (acoustic schwannoma and meningioma</p>\n</td>\n<td>\n<p>Schwannoma, meningioma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>PTCH</em></p>\n</td>\n<td>\n<p>Patched</p>\n</td>\n<td>\n<p>Inhibitor of Hedgehog signaling</p>\n</td>\n<td>\n<p>Gorlin syndrome (basal cell carcinoma, medulloblastoma, several benign tumors)</p>\n</td>\n<td>\n<p>Basal cell carcinoma, medulloblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>PTEN</em></p>\n</td>\n<td>\n<p>Phosphatase and tensin homologue</p>\n</td>\n<td>\n<p>Inhibitor of PI3K/AKT signaling</p>\n</td>\n<td>\n<p>Cowden syndrome (variety of benign skin, GI and CNS growths; Breast, endometrial and thyroid carcinoma)</p>\n</td>\n<td>\n<p>Diverse cancers, particularly carcinomas and lymphoid tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>SMAD2, SMAD4</em></p>\n</td>\n<td>\n<p>SMAD2, SMAD4</p>\n</td>\n<td>\n<p>Component of TGFb signaling pathway, repressors of MYC and CDK4 expression, inducers of CDK inhibitor expression</p>\n</td>\n<td>\n<p>Juvenile polyposis</p>\n</td>\n<td>\n<p>Frequently mutated (along with other components of the TGFb signaling pathway) in colonic and pancreatic carcinoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4184",
      "difficulty": "medium"
    },
    {
      "text": "A 24-year-old woman presented with hearing loss and tinnitus. MRI was done and showed the presence of bilateral acoustic schwannomas. Which protein involved in cytoskeletal stability is mutated in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Neurofibromin"
        },
        {
          "id": 2,
          "text": "Merlin"
        },
        {
          "id": 3,
          "text": "PATCHED"
        },
        {
          "id": 4,
          "text": "RB protein"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario and MRI findings are suggestive of<strong> neurofibromatosis type 2</strong> (NF-2). <strong>Merlin</strong> protein is&nbsp;mutated in NF-2, sporadic schwannomas, and meningiomas.</p>\n<p>Cells lacking Merlin do not establish stable cell-to-cell junctions. They are insensitive to normal growth arrest signals generated by cell-to-cell contact.</p><hr><h3>Related Pearl: Inhibitors of Mitogenic Signaling Pathway</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Gene</strong></p>\n</td>\n<td>\n<p><strong>Protein</strong></p>\n</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n<td>\n<p><strong>Familial Syndromes</strong></p>\n</td>\n<td>\n<p><strong>Sporadic Cancers</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>APC</em></p>\n</td>\n<td>\n<p>Adenomatous polyposis coli protein</p>\n</td>\n<td>\n<p>Inhibitor of WNT signaling</p>\n</td>\n<td>\n<p>Familial colonic polyps and carcinomas</p>\n</td>\n<td>\n<p>Carcinomas of stomach, colon, pancreas, melanoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>NF1</em></p>\n</td>\n<td>\n<p>Neurofibromin-1</p>\n</td>\n<td>\n<p>Inhibitor of RAS/MAPK signaling</p>\n</td>\n<td>\n<p>Neurofibromatosis type 1</p>\n<p>(neurofibromas and malignant peripheral nerve sheath tumors)</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Neuroblastoma, juvenile myeloid leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>NF2</em></p>\n</td>\n<td>\n<p>Merlin</p>\n</td>\n<td>\n<p>Cytoskeletal stability, Hippo pathway signaling</p>\n</td>\n<td>\n<p>Neurofibromatosis type 2 (acoustic schwannoma and meningioma</p>\n</td>\n<td>\n<p>Schwannoma, meningioma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>PTCH</em></p>\n</td>\n<td>\n<p>Patched</p>\n</td>\n<td>\n<p>Inhibitor of Hedgehog signaling</p>\n</td>\n<td>\n<p>Gorlin syndrome (basal cell carcinoma, medulloblastoma, several benign tumors)</p>\n</td>\n<td>\n<p>Basal cell carcinoma, medulloblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>PTEN</em></p>\n</td>\n<td>\n<p>Phosphatase and tensin homologue</p>\n</td>\n<td>\n<p>Inhibitor of PI3K/AKT signaling</p>\n</td>\n<td>\n<p>Cowden syndrome (variety of benign skin, GI and CNS growths; Breast, endometrial and thyroid carcinoma)</p>\n</td>\n<td>\n<p>Diverse cancers, particularly carcinomas and lymphoid tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>SMAD2, SMAD4</em></p>\n</td>\n<td>\n<p>SMAD2, SMAD4</p>\n</td>\n<td>\n<p>Component of TGFb signaling pathway, repressors of MYC and CDK4 expression, inducers of CDK inhibitor expression</p>\n</td>\n<td>\n<p>Juvenile polyposis</p>\n</td>\n<td>\n<p>Frequently mutated (along with other components of the TGFb signaling pathway) in colonic and pancreatic carcinoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4186",
      "difficulty": "medium"
    },
    {
      "text": "Germline loss-of-function mutation of which gene causes Gorlin syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "STK11"
        },
        {
          "id": 2,
          "text": "SDHB"
        },
        {
          "id": 3,
          "text": "WT1"
        },
        {
          "id": 4,
          "text": "PTCH1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Germline loss-of-function mutations of the<strong> PTCH1 </strong>gene cause<strong> Gorlin syndrome.</strong></p>\n<p>Gorlin syndrome is an <strong>autosomal-dominant</strong> disorder. Clinical features include:</p>\n<ul>\n<li>Multiple basal cell carcinomas</li>\n<li>Highly characteristic facies - large forehead</li>\n<li>Bifid or misshapen ribs</li>\n<li>Vertebral and other skeletal anomalies</li>\n<li>Pits of the skin of&nbsp;the palms and soles</li>\n<li>Dysgenesis of the corpus callosum</li>\n<li>Calcification of the falx cerebri - at an earlier age than is seen in non‐affected individuals</li>\n<li>Macrocephaly</li>\n</ul>\n<p>Acquired biallelic loss-of-function mutations of <em>PTCH1</em>&nbsp;cause sporadic basal cell carcinomas and medulloblastoma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4187",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old man patient presents with anemia and abdominal pain. On examination, he has pigmented macules over the palms, soles, and oral mucosa. Further investigations reveal loss-of-function mutations of the STK11 gene. What is the most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "HNPCC"
        },
        {
          "id": 2,
          "text": "Gorlin syndrome"
        },
        {
          "id": 3,
          "text": "von Hipple-Lindau syndrome"
        },
        {
          "id": 4,
          "text": "Peutz-Jeghers syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario is suggestive of <strong>Peutz&ndash;Jeghers syndrome</strong>.</p>\n<p>Loss-of-function mutations of <strong>STK11</strong> cause the<strong>&nbsp;</strong>Peutz&ndash;Jeghers syndrome<strong>.&nbsp;</strong>The STK22&nbsp;gene, also known as<strong> <em>LKB1</em>, </strong>encodes a serine/threonine kinase that is an important regulator of cellular metabolism.</p>\n<p>Peutz-Jeghers syndrome is an <strong>autosomal-dominant</strong> disorder. It is associated with arborizing <strong>polyps</strong> of the <strong>gastrointestinal tract</strong> (small intestine &gt; colon &gt; stomach). It increases the risk of multiple epithelial cancers, particularly of colon, breast, lung, pancreas, and thyroid.</p><hr><h3>Related Pearl: Peutz–Jeghers Syndrome</h3><ul>\n<li>Autosomal-dominant disease</li>\n<li>Germline defects in the <strong>tumor suppressor </strong>serine-threonine kinase 11 (<strong><em>STK11</em></strong>) gene on<strong> chromosome 19.</strong></li>\n</ul>\n<p><strong>Features</strong>:</p>\n<ul>\n<li><strong>Hyperpigmentation</strong> of the buccal mucosa, lips, and digits</li>\n<li><strong>Hamartomatous polyps</strong> of the intestinal tract</li>\n<li>Increased (2% to 10%) risk for <strong>cancer</strong> of the<strong> intestinal tract</strong>&nbsp;(stomach - rectum).</li>\n<li>Increased risk for <strong>extraintestinal malig&shy;nant neoplasms</strong>, including cancer of the breast, ovary, cervix, fallopian tubes, thyroid, lung, gallbladder, bile ducts, pancreas, and testicles.</li>\n</ul>\n<p><strong>Screening</strong>:&nbsp;Baseline colonoscopy and upper endoscopy at age 20 years, followed by annual flexible sigmoidoscopy thereafter.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eff8622ebbed495bb2c50bb2544cdb48x450x600.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1160ec99452648149a62ef6cadaef74ex418x532.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Histologic image</strong> showing the characteristic arborizing network of connective tissue, smooth muscle, lamina propria, and glands lined by normal-appearing intestinal epithelium:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e7f25b73d84249949d85119e7bd2cc28x1280x1863.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4188",
      "difficulty": "medium"
    },
    {
      "text": "A 38-year-old woman presents with complaints of a palpable mass in both breasts. Histopathology examination shows the following finding. Immunohistochemistry showed estrogen receptor positivity. Which protein that maintains cell adhesion, and thereby inhibits cell motility, is mutated in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "p63"
        },
        {
          "id": 2,
          "text": "p53"
        },
        {
          "id": 3,
          "text": "E Cadherin"
        },
        {
          "id": 4,
          "text": "Integrin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of <strong>lobular carcinoma</strong> of the<strong> breast</strong>&nbsp;which involves mutated<strong>&nbsp;E-cadherin</strong>&nbsp;protein. In this condition, the histopathological examination shows&nbsp;infiltrating small monomorphic discohesive tumor cells arranged in an&nbsp;<strong>Indian-file&nbsp;</strong>or&nbsp;<strong>single-file pattern.</strong></p>\n<p>The image below shows the single file pattern seen in lobular carcinoma of the breast.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/052debaf560e4004827f06fa2e7c875dx1279x1253.JPEG\" alt=\"Explanation Image\"><p>Reduced cell surface expression of <strong>E</strong><strong>-cadherin</strong> is seen in carcinomas of:</p>\n<ul>\n<li>Breast</li>\n<li>Esophagus</li>\n<li>Colon</li>\n<li>Ovary</li>\n<li>Prostate</li>\n</ul>\n<p>E-cadherin is a cell-surface protein that maintains intercellular <strong>adhesiveness</strong>.&nbsp;Loss of E-cadherin causes <strong>disaggregation</strong> of cells, which can then invade locally or <strong>metastasize.</strong></p>\n<p>Germline loss-of-function mutations of the E-cadherin gene lead to <strong>familial gastric carcinoma.&nbsp;</strong>Sporadic gastric carcinomas are also associated with the loss of E-cadherin expression.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/95450a6982aa44c19681836bd4b26dfd.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4190",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is incorrect regarding the BRCA genes?",
      "choices": [
        {
          "id": 1,
          "text": "BRCA1 is located on the long arm of chromosome 17"
        },
        {
          "id": 2,
          "text": "BRCA1 mutation causes well-differentiated cancer"
        },
        {
          "id": 3,
          "text": "BRCA2 carcinomas are ER/PR- positive"
        },
        {
          "id": 4,
          "text": "BRCA 2 mutation is associated with male breast carcinoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>BRCA2</strong> (not BRCA 1) mutation causes&nbsp;<strong>well-differentiated</strong> cancer.</p><hr><h3>Related Pearl: Comparison between BRCA 1 and BRCA 2:</h3><div class=\"panel-body ng-scope\">\n<p>Both <em>BRCA1</em> and <em>BRCA2</em> are <strong>tumor suppressor genes.</strong></p>\n<p>Carcinoma breast <strong>occurs at an earlier age</strong> and is <strong>bilateral and multicentric in </strong>inherited forms compared to sporadic cases.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>BRCA 1</strong></td>\n<td><strong>BRCA 2</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Long arm of <strong>chromosome 17</strong>&nbsp;</td>\n<td>Long arm of <strong>chromosome 13</strong></td>\n</tr>\n<tr>\n<td>Differentiation</td>\n<td>Poorly differentiated</td>\n<td>Well-differentiated</td>\n</tr>\n<tr>\n<td>Hormone receptor status</td>\n<td>ER/PR- Negative, Her-2 negative &ndash; triple negative</td>\n<td>ER/PR- Positive</td>\n</tr>\n<tr>\n<td>Associated Cancers</td>\n<td>Breast, ovarian, colon, and prostate (lesser extent), Pancreas (lesser extent)&nbsp; cancers</td>\n<td>Breast, ovarian, colon, prostate, pancreas, gall bladder, stomach cancers, and melanoma</td>\n</tr>\n<tr>\n<td>Male breast carcinoma</td>\n<td>Low risk</td>\n<td><strong>Increased risk</strong></td>\n</tr>\n<tr>\n<td>Fanconi&rsquo;s anemia</td>\n<td>Not associated</td>\n<td>Associated</td>\n</tr>\n<tr>\n<td>Medullary carcinoma</td>\n<td>Associated</td>\n<td>Not associated</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4191",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is incorrect regarding apoptosis?",
      "choices": [
        {
          "id": 1,
          "text": "p53 induces apoptosis in cells with DNA damage"
        },
        {
          "id": 2,
          "text": "Extrinsic apoptotic pathway is more frequently disabled in cancer cells"
        },
        {
          "id": 3,
          "text": "Chemoradiation induces apoptosis in cancer cells"
        },
        {
          "id": 4,
          "text": "BCL2 is over-expressed in follicular lymphomas"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 310\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The <strong>intrinsic </strong>apoptotic pathway is most frequently <strong>disabled</strong> in <strong>cancer cells</strong> to evade cell death.&nbsp;</p>\n</div>\n</div>\n</div>\n<p><strong>p53</strong> is an important pro-apoptotic protein that induces apoptosis in cells that are unable to repair DNA damage.</p>\n<p class=\"p1\"><strong>Chemotherapy</strong> and <strong>radiation</strong> therapy kills cancer cells mainly by inducing apoptosis via the intrinsic pathway.</p>\n<p>In greater than&nbsp;85% of follicular B-cell lymphomas, the anti-apoptotic gene&nbsp;<em><strong>BCL2</strong>&nbsp;</em>is overexpressed due to a (14;18) translocation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4193",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following genes promote epithelial-mesenchymal transition in epithelial tumors?<div class='question-desc-html'><ol>\n<li>MYC</li>\n<li>SNAIL</li>\n<li>TWIST</li>\n<li>BRCA1</li>\n<li>RET</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 3 only"
        },
        {
          "id": 2,
          "text": "2, 3, and 5 only"
        },
        {
          "id": 3,
          "text": "4 and 5 only"
        },
        {
          "id": 4,
          "text": "2 and 3 only"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>SNAIL </strong>and<strong> TWIST,</strong> which encode transcription factors, promote epithelial-to-mesenchymal transition (<strong>EMT</strong>).</p>\n<p>In EMT, carcinoma cells <strong>downregulate </strong>certain epithelial markers (e.g.,<strong> E-cadherin</strong>) and<strong> upregulate </strong>certain mesenchymal markers (e.g.<strong> vimentin </strong>and<strong> smooth muscle actin</strong>).&nbsp;This favors the development of a promigratory phenotype that is essential for <strong>metastasis</strong>.&nbsp;EMT has been documented mainly in<strong> breast carcinoma.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4195",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a non-receptor tyrosine kinase?",
      "choices": [
        {
          "id": 1,
          "text": "ABL"
        },
        {
          "id": 2,
          "text": "RET"
        },
        {
          "id": 3,
          "text": "KIT"
        },
        {
          "id": 4,
          "text": "ALK"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>ABL </strong>is a<strong>&nbsp;non-receptor tyrosine kinase.</strong></p>\n<p><strong>Tyrosine kinases</strong>&nbsp;may be receptors and non-receptors.</p>\n<p><strong>Nonreceptor </strong>tyrosine kinases normally localize to the cytoplasm or the nucleus. These are:</p>\n<ul>\n<li><strong>ABL</strong>&nbsp;- translocation causes CML and point mutation causes ALL</li>\n<li><strong>JAK</strong> mutation - seen in polycythemia vera, essential thrombocythemia, and myelofibrosis as well as other myeloproliferative disorders</li>\n</ul>\n<p><strong>Receptor </strong>tyrosine kinases:</p>\n<ul>\n<li>VEGFR</li>\n<li>PDGFR</li>\n<li>EGFR</li>\n</ul>\n<p>In chronic myelogenous leukemia (<strong>CML</strong>) and some acute lymphoblastic leukemia (<strong>ALL</strong>), the <em>ABL</em> gene is translocated from its normal abode on chromosome 9 to chromosome 22 where it fuses with the <em>BCR</em> gene forming the <strong>Philadelphia chromosome</strong>.&nbsp;The resultant chimeric gene <strong>encodes</strong> a constitutively active, <strong>oncogenic</strong> BCR-ABL<strong> tyrosine kinase</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4291",
      "difficulty": "medium"
    },
    {
      "text": "The mutations/changes that convert proto-oncogene to oncogene include all except:",
      "choices": [
        {
          "id": 1,
          "text": "Promoter insertion"
        },
        {
          "id": 2,
          "text": "Enhancer deletion"
        },
        {
          "id": 3,
          "text": "Gene amplification"
        },
        {
          "id": 4,
          "text": "Point mutation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Enhancer deletion does not convert a proto-oncogene to an oncogene.</p>\n<p>Mechanisms of activating oncogenes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Mechanism</strong></td>\n<td><strong>Activation of oncogenes</strong></td>\n</tr>\n<tr>\n<td>Mutation</td>\n<td>Mutation activates the gene. A classic example is the point mutation of the RAS oncogene.</td>\n</tr>\n<tr>\n<td>Promoter insertion&nbsp;</td>\n<td>Insertion of a viral promoter region near a gene activates it.</td>\n</tr>\n<tr>\n<td>Enhancer insertion&nbsp;</td>\n<td>Insertion of a viral enhancer region near a gene activates it.</td>\n</tr>\n<tr>\n<td>Chromosomal translocation&nbsp;</td>\n<td>One chromosome is split off and joined to another. An example is the Philadelphia chromosome.</td>\n</tr>\n<tr>\n<td>Gene amplification&nbsp;&nbsp;</td>\n<td>Abnormal multiplication of a gene resulting in many copies. This can occur with oncogenes and genes involved in tumor drug resistance.&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0153",
      "difficulty": "medium"
    },
    {
      "text": "Mutation in which of the following oncogenes can serve as a tumor antigen?",
      "choices": [
        {
          "id": 1,
          "text": "EBNA"
        },
        {
          "id": 2,
          "text": "MUC-1"
        },
        {
          "id": 3,
          "text": "p53"
        },
        {
          "id": 4,
          "text": "RAS"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>RAS</strong> is an <strong>oncogene</strong> that undergoes mutation and serves as a&nbsp;<strong>tumor antigen</strong>.</p>\n<p>Tumor cells express antigenic molecules on their surface that elicit an immune response. These are called tumor antigens. Some tumor cells evade immune response which results in growth of the tumor.</p><hr><h3>Related Pearl: Tumor antigens recognized by CD8+ T cells</h3><p><strong>Antitumor activity</strong> is mediated predominantly by cell-mediated mechanisms. <strong>Tumor</strong> <strong>antigens</strong> are presented on the cell surface by <strong>MHC class I molecules</strong> and are recognized by <strong>CD8+ CTLs</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Tumor antigen class</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td>Products of mutated genes</td>\n<td>\n<p><strong>Oncogene products</strong>: mutated <em>RAS</em>, BCR/ABL fusion protein</p>\n<p><strong>Tumor suppressor gene</strong> <strong>products</strong>: mutated p53 protein</p>\n</td>\n</tr>\n<tr>\n<td>Over/aberrantly expressed cellular proteins</td>\n<td>\n<p><strong>Overexpressed</strong>: tyrosinase, gp100, MART in melanomas</p>\n<p><strong>Aberrantly expressed</strong>: cancer-testis antigens (MAGE, BAGE)</p>\n</td>\n</tr>\n<tr>\n<td>Tumor antigens produced by oncogenic viruses</td>\n<td>\n<p>Human papilloma virus&nbsp;proteins E6 and E7 in cervical carcinoma</p>\n<p>EBNA proteins in Epstein&ndash;Barr virus-induced -lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>Oncofetal antigens</td>\n<td>Carcinoembryonic antigen (CEA), &alpha;-fetoprotein (AFP).</td>\n</tr>\n<tr>\n<td>Altered cell surface glycolipids and glycoproteins</td>\n<td>\n<p><strong>CA-125, CA-19-9</strong> expressed on ovarian carcinomas.</p>\n<p><strong>MUC-1</strong> expressed in both ovarian and breast carcinomas</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2232",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following mechanisms does not lead to immune evasion by the tumor cells?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibition of PD-1 receptor on T-cells"
        },
        {
          "id": 2,
          "text": "Upregulation of expression of PD-L1"
        },
        {
          "id": 3,
          "text": "Induction of galactin"
        },
        {
          "id": 4,
          "text": "Induction of regulatory T-cells"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Inhibition </strong>of<strong>&nbsp;PD-1 receptor&nbsp;</strong>(programmed death -1 receptor) on T cells causes activation of <strong>immunity</strong> against the <strong>tumor</strong> cells, not evasion.</p>\n<p>PD-1 receptors present on T cells inhibit T-cell activation. This allows tumors to<strong> evade </strong>the<strong> host immunity</strong> by the <strong>upregulation</strong> of the expression of factors like <strong>PD-L1 </strong>and<strong> PD-L2,</strong> which act on PD-1 receptors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2233",
      "difficulty": "hard"
    },
    {
      "text": "An 8-year-old girl is referred with recurrent blistering rashes over the face and upper limbs which worsened following exposure to sunlight. There is a history of similar skin lesions in her family and 2 of her uncles were diagnosed with skin cancers at young ages. Examination reveals the presence of multiple lentigos and xerosis. What is the likely pathological mechanism of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Defective base excision repair"
        },
        {
          "id": 2,
          "text": "Defective DNA nucleotide excision repair"
        },
        {
          "id": 3,
          "text": "Defective mismatch repair"
        },
        {
          "id": 4,
          "text": "Defective non-homologous end joining repair"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>xeroderma pigmentosum. </strong>It<strong>&nbsp;</strong>is caused by a <strong>defect</strong> in the <strong>DNA</strong>&nbsp;<strong>nucleotide excision repair</strong> pathway resulting in&nbsp;inability to repair<strong> pyrimidine dimers.</strong></p>\n<p><strong>Clinical features</strong> of xeroderma pigmentosum:</p>\n<ul>\n<li>Actinic keratosis</li>\n<li>Hyperkeratotic lesions</li>\n<li>Multiple lentigos</li>\n<li>Xerosis</li>\n<li>Corneal scarring</li>\n</ul>\n<p>The image of a child with xeroderma pigmentosum is given below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/beaea49c0bb54865872a7c519217de3ex720x540.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: DNA Repair Mechanisms</h3><table>\n<tbody>\n<tr>\n<td><strong>Damaging agents</strong></td>\n<td><strong>Damage caused</strong></td>\n<td><strong>Repair mechanisms</strong></td>\n</tr>\n<tr>\n<td>\n<p>Ionizing radiation</p>\n<p>X-rays</p>\n<p>Anti-tumor drugs</p>\n</td>\n<td>\n<p>Double-strand breaks</p>\n<p>Single-strand breaks</p>\n<p>Intrastrand crosslinks</p>\n<p>Interstrand crosslinks</p>\n</td>\n<td>Non-homologous end joining (NHEJ)</td>\n</tr>\n<tr>\n<td>\n<p>UV light</p>\n<p>Chemicals</p>\n</td>\n<td>\n<p>Bulky adducts</p>\n<p>Pyrimidine dimers</p>\n</td>\n<td>Nucleotide excision repair (NER)</td>\n</tr>\n<tr>\n<td>\n<p>Oxygen radicals</p>\n<p>Hydrolysis&nbsp;</p>\n<p>Alkylating agents</p>\n</td>\n<td>\n<p>Abasic sites single-strand breaks</p>\n<p>8-oxoguanine lesions</p>\n</td>\n<td>Base excision repair (BER)</td>\n</tr>\n<tr>\n<td>Replication errors</td>\n<td>\n<p>Bases mismatch</p>\n<p>Insertions</p>\n<p>Deletions</p>\n</td>\n<td>Mismatch repair (MMR)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4053",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following disorders is not associated with defective homologous recombination DNA repair mechanism?",
      "choices": [
        {
          "id": 1,
          "text": "Familial breast cancer"
        },
        {
          "id": 2,
          "text": "Fanconi anemia"
        },
        {
          "id": 3,
          "text": "Fanconi syndrome"
        },
        {
          "id": 4,
          "text": "Ataxia-telengeictasia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Fanconi syndrome</strong> is not associated with defective homologous recombination DNA repair mechanism. It is a rare disorder of <strong>kidney tubule function.</strong></p>\n<p>Diseases with<strong> defects </strong>in<strong> DNA repair</strong> by <strong>homologous recombination:</strong></p>\n<ul>\n<li><strong>Bloom syndrome</strong> and <strong>ataxia–telangiectasia </strong>triggered by DNA-damaging agents such as ionizing radiation</li>\n<li><strong>Fanconi anemia </strong>is an autosomal recessive disease caused by mutations in multiple genes responsible for coding for proteins that participate in DNA repair pathways and are triggered by DNA-crosslinking agents like chemotherapeutic drugs.</li>\n<li><strong>Familial breast cancer</strong> is due to inherited gene defects in BRCA1 and BRCA 2 genes</li>\n</ul><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4054",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old patient presents with right iliac fossa pain. Imaging shows the presence of an ileocaecal mass. Biopsy of the mass shows a starry sky pattern. What is the translocation involved in this tumor?",
      "choices": [
        {
          "id": 1,
          "text": "t(8;14)"
        },
        {
          "id": 2,
          "text": "t(15;17)"
        },
        {
          "id": 3,
          "text": "t(9;22)"
        },
        {
          "id": 4,
          "text": "t(11;14)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical history and biopsy findings are suggestive of<strong>&nbsp;Burkitt lymphoma&nbsp;</strong>and the translocation involved is<strong> t(8;14)</strong>.</p>\n<p><strong>Burkitt lymphoma</strong>, also known as <strong>small non-cleaved-cell lymphoma</strong>, is a highly aggressive <strong>B-cell non-Hodgkin lymphoma.</strong>&nbsp;It is characterized by the translocation and deregulation of the <strong>c-myc gene</strong> on <strong>chromosome 8.&nbsp;</strong></p>\n<p>The classic t(8;14)(q24;q32) <strong>reciprocal translocation</strong> results in the transposition of the <strong>c-myc proto-oncogene </strong>on chromosome 8 with one of the immunoglobulin heavy chain (<strong>IGH</strong>) genes on chromosome 14. This results in <strong>activation</strong> of the <strong>c-myc</strong> gene and is considered responsible for tumor proliferation.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fab582207ff84dc0b37d9d26eb4bd57bx754x560.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4055",
      "difficulty": "medium"
    },
    {
      "text": "Which epigenomic regulatory gene is mutated in most of the follicular lymphomas?",
      "choices": [
        {
          "id": 1,
          "text": "MLL1"
        },
        {
          "id": 2,
          "text": "MLL2"
        },
        {
          "id": 3,
          "text": "ARID1A"
        },
        {
          "id": 4,
          "text": "SNF5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>MLL2&nbsp;</strong>is an epigenomic regulatory gene that is mutated in most&nbsp;<strong>follicular lymphomas</strong>. It results in <strong>histone methylation</strong>.</p>\n<p><strong>Epigenetics&nbsp;</strong>refers to <strong>factors</strong> other than the sequence of DNA that <strong>regulate gene expression</strong>.&nbsp;These factors involved in epigenetics are:</p>\n<ul>\n<li>Histone modifications</li>\n<li>DNA methylation</li>\n<li>Nucleosome positioning/ chromatin remodeling</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4056",
      "difficulty": "medium"
    },
    {
      "text": "The loss of which of the following micro RNAs leads to upregulation of BCL-2?",
      "choices": [
        {
          "id": 1,
          "text": "miR-200"
        },
        {
          "id": 2,
          "text": "miR-15"
        },
        {
          "id": 3,
          "text": "miR-155"
        },
        {
          "id": 4,
          "text": "miR-25"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>loss</strong> of <strong>miR-15</strong> leads to upregulation of the <strong>anti-apoptotic</strong> protein <strong>BCL-2</strong>.</p>\n<p><strong>miR-15</strong> and <strong>miR-16</strong> are <strong>tumor-suppressive</strong> miRNAs involved in chronic lymphocytic leukemia (<strong>CLL</strong>).</p>\n<p><strong>Onco-miRNAs</strong> include:</p>\n<ul>\n<li><strong>miR200 -&nbsp;</strong>promotes&nbsp;<strong>epithelial-mesenchymal transitions </strong>that promote tumor invasion&nbsp;and metastasis</li>\n<li><strong>miR155 - </strong>involved in<strong>&nbsp;</strong>human <strong>B-cell lymphomas</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4059",
      "difficulty": "medium"
    },
    {
      "text": "Identify the correct statement regarding immune surveillance.",
      "choices": [
        {
          "id": 1,
          "text": "Anti CTLA 4 Ab is a new modality in the treatment of advanced cancers"
        },
        {
          "id": 2,
          "text": "Mutation of tumor supressor genes decreases antigen toxicity"
        },
        {
          "id": 3,
          "text": "PD1/ PDL1 activation leading to tumor supression"
        },
        {
          "id": 4,
          "text": "Binding of CD28 leads to immune tolerance"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span><strong>Anti-CTLA-4 antibody ipilimumab</strong> was the <strong>first drug</strong> to achieve a significant <strong>improvement</strong> in<strong> survival</strong> of<strong> advanced-stage melanoma</strong>. Cytotoxic T lymphocyte antigen 4 (CTLA-4) plays an important inhibitory role in the control of T-cell activation.</span></p>\n<p><span>Ipilimumab is a fully-humanized <strong>IgG1 monoclonal antibody</strong> that inhibits cytotoxic T lymphocyte antigen-4 (CTLA-4).</span></p>\n<p><span>It has been postulated that anti-CTLA-4 antibodies act by blocking inhibitory signals from effector T-cells, allowing costimulatory signaling and generation of antitumor T-cell responses. In vitro studies demonstrated also that the antitumor activity of CTLA-4 blockade is mediated by Fc gamma receptor-expressing macrophage and hypothesized a possible role of regulatory T-cell depletion in the tumor microenvironment.</span></p>\n<p><span>Option B - Mutation of tumor supressor genes is associated with increased risk of cancer. Antigen toxicity is when the immune response to an antigen is excessive or misdirected, causing damage to tissues or organs.</span></p>\n<p><span>Option C - <strong>PD1/PDL1</strong> is an immune checkpoint whose <strong>activation inhibits T-cell function</strong> and helps with <strong>immune tolerance</strong>. Blocking PD-1/PD-L1 interaction using immune checkpoint inhibitors reactivates T cells and enhances immune responses against tumors.</span></p>\n<p><span>Option D - <strong>CD28</strong> is primarily involved in providing the <strong>second signal</strong> required for <strong>T cell activation</strong>. The first signal comes from the interaction between the T cell receptor (TCR) and the antigen presented by the major histocompatibility complex (MHC) on antigen-presenting cells (APCs). <strong>Without</strong> CD28-mediated costimulation, T cells that only receive the TCR signal (without the second signal) can become<strong> anergic</strong>.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6771",
      "difficulty": "medium"
    }
  ]
}